Loading clinical trials...
Loading clinical trials...
An Adaptive Randomised Controlled Trial to Treat Polyomavirus Infections (BKPyV) in Kidney and Kidney Pancreas Transplant Recipients
Conditions
Interventions
Immunosuppression reduction/modification + intravenous immunoglobulin
Immunosuppression reduction/modification
Locations
12
Australia
Canberra Hospital
Canberra, Australian Capital Territory, Australia
John Hunter Hospital
New Lambton Heights, New South Wales, Australia
Prince of Wales Hospital
Randwick, New South Wales, Australia
Royal Prince Alfred Hospital
Sydney, New South Wales, Australia
The Childrens Hospital Westmead
Sydney, New South Wales, Australia
Western Sydney Local Health District (Westmead Hospital)
Westmead, New South Wales, Australia
Start Date
August 18, 2023
Primary Completion Date
August 1, 2027
Completion Date
June 30, 2029
Last Updated
March 30, 2026
NCT04542733
NCT05525507
NCT05224583
NCT06825117
NCT05806749
NCT03380962
Lead Sponsor
The University of Queensland
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions